Newly Diagnosed Glioblastoma research hub
3 indexed studies · 2 currently recruiting
- recruitingPHASE1, PHASE2
New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
This study is testing a new 'vaccine' for people with newly diagnosed glioblastoma, a type of brain cancer. It aims to see if it's safe and helps the body's immune system fight the cancer after standard treatments. This research could lead to bigger studies in the future.
France - recruitingPHASE1, PHASE2
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
This study is testing a new gene therapy, TGX-007, for an aggressive type of brain tumour called glioblastoma. It aims to find the safest dose and see how well it works. TGX-007 helps the body fight the cancer by working with a common antiviral medicine, valaciclovir.
United States · United Kingdom - active not recruitingPHASE1, PHASE2
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
This study is testing a new drug, ST101, for people with advanced cancers like breast cancer, melanoma, and glioblastoma. It aims to see if the drug is safe, how much to give, and if it could help shrink tumors. It's for adults whose cancer hasn't responded to other treatments.
United States · United Kingdom